PATENT CLAIM ANALYSIS

Application Number: 16250278
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["514", "274000"]

Abstract:
The present invention relates to compounds that may be used in the treatment of Parkinson's disease, anxiety, emesis, obsessive compulsive disorder, autism, neuroprotection, cancer, depression or diabetes type 2.

Claim (Index 1):
A compound of formula IA or IB or a pharmaceutically acceptable salt or acid addition salt, a racemic mixture, or its corresponding enantiomer and/or optical isomer and/or stereoisomer thereof.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 99.0
- Lexical Diversity: 1.1875
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15869268', '15707848', '15245955', '15867097', '15205466']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7537908266134105
- 35 USC 102 Novelty (BERT): 0.5321908888804241
- Combined Prediction Score: 0.7316308328401118
- Mean Citation Score: 270.238132
- Max Citation Score: 338.14395
- Similarity Product: 271.91657801596824

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test